pic.twitter.com/CdCexvouxN— Dan Scavino Jr.🇺🇸🦅 (@DanScavino) January 17, 2022
Below posted on GAW. :D
https://greatawakening.win/p/141F16q5DM/again-dan-sqavino-rides-in-with-/c/
Most people know that vitamin C supports the immune system. This finding is backed up by several studies and yet hospitals rarely use it to treat COVID-19.
Indeed, a review of 12 studies, including five “gold standard” randomized controlled trials, shows that this simple vitamin saves lives when given in the right dose. The review, which was published in the journal Life, was carried out and funded by VitaminC4Covid, a consortium of vitamin C experts including Dr. Marcela Vizcaychipi from the Faculty of Medicine at London’s Imperial College, Associate Professor Anitra Carr, who heads the Nutrition in Medicine group at the University of Otago, and Dr. Paul Marik, chief of the Division of Pulmonary & Critical Care Medicine, Eastern Virginia Medical School.
The studies show that COVID-19 patients have depleted vitamin C levels, often to the level found in scurvy. In patients with serious pneumonia, a depleted vitamin C level greatly increases the risk of widespread internal organ damage and death. They need substantial doses of vitamin C to recover and survive.
In the United States, a group of medical doctors, members of the Frontline COVID Critical Care Alliance (www.flccc.net) have more than halved mortality in their ICUs using the MATH+ protocol of steroids (methylprednisolone), vitamin C (ascorbic acid), vitamin B1 (thiamine), vitamin D, and anticoagulants (heparin). This protocol was pioneered by Drs. Paul Marik, Pierre Kory, and Joseph Varon, a critical care expert recognized by the United Nations for his life-saving work.
According to the review, the 12 clinical trials show that “intravenous vitamin C may improve oxygenation parameters, reduce inflammatory markers, decrease days in the hospital, and reduce mortality, particularly in the more severely ill patients.”
What is remarkable about vitamin C is that it’s an antioxidant, an anti-viral, and also anti-inflammatory. It’s an impressive three-in-one defender. Not one adverse event has been reported in any published vitamin C clinical trials in COVID-19 patients.
The review also shows that high doses of oral vitamin C taken upon infection may keep people out of the hospital because it increases their rate of recovery.
According to Carr, “Oral doses of 8 grams per day have been shown to increase the rate of recovery from symptomatic infection by 70 percent. For more critically ill patients, trials using doses of 6-24g a day intravenously have shown positive benefits in terms of increased survival, and reduced hospital stay, improved oxygenation, or reduced inflammation.”
pic.twitter.com/CdCexvouxN— Dan Scavino Jr.🇺🇸🦅 (@DanScavino) January 17, 2022
Most people know that vitamin C supports the immune system. This finding is backed up by several studies and yet hospitals rarely use it to treat COVID-19.
Indeed, a review of 12 studies, including five “gold standard” randomized controlled trials, shows that this simple vitamin saves lives when given in the right dose. The review, which was published in the journal Life, was carried out and funded by VitaminC4Covid, a consortium of vitamin C experts including Dr. Marcela Vizcaychipi from the Faculty of Medicine at London’s Imperial College, Associate Professor Anitra Carr, who heads the Nutrition in Medicine group at the University of Otago, and Dr. Paul Marik, chief of the Division of Pulmonary & Critical Care Medicine, Eastern Virginia Medical School.
The studies show that COVID-19 patients have depleted vitamin C levels, often to the level found in scurvy. In patients with serious pneumonia, a depleted vitamin C level greatly increases the risk of widespread internal organ damage and death. They need substantial doses of vitamin C to recover and survive.
In the United States, a group of medical doctors, members of the Frontline COVID Critical Care Alliance (www.flccc.net) have more than halved mortality in their ICUs using the MATH+ protocol of steroids (methylprednisolone), vitamin C (ascorbic acid), vitamin B1 (thiamine), vitamin D, and anticoagulants (heparin). This protocol was pioneered by Drs. Paul Marik, Pierre Kory, and Joseph Varon, a critical care expert recognized by the United Nations for his life-saving work.
According to the review, the 12 clinical trials show that “intravenous vitamin C may improve oxygenation parameters, reduce inflammatory markers, decrease days in the hospital, and reduce mortality, particularly in the more severely ill patients.”
What is remarkable about vitamin C is that it’s an antioxidant, an anti-viral, and also anti-inflammatory. It’s an impressive three-in-one defender. Not one adverse event has been reported in any published vitamin C clinical trials in COVID-19 patients.
The review also shows that high doses of oral vitamin C taken upon infection may keep people out of the hospital because it increases their rate of recovery.
According to Carr, “Oral doses of 8 grams per day have been shown to increase the rate of recovery from symptomatic infection by 70 percent. For more critically ill patients, trials using doses of 6-24g a day intravenously have shown positive benefits in terms of increased survival, and reduced hospital stay, improved oxygenation, or reduced inflammation.”